Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D0NG
|
|||
| Former ID |
DNC009012
|
|||
| Drug Name |
4-(cyclohexylmethylcarbamoyloxy)benzoic acid
|
|||
| Synonyms |
CHEMBL465214; 4-(cyclohexylmethylcarbamoyloxy)benzoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H19NO4
|
|||
| Canonical SMILES |
C1CCC(CC1)CNC(=O)OC2=CC=C(C=C2)C(=O)O
|
|||
| InChI |
1S/C15H19NO4/c17-14(18)12-6-8-13(9-7-12)20-15(19)16-10-11-4-2-1-3-5-11/h6-9,11H,1-5,10H2,(H,16,19)(H,17,18)
|
|||
| InChIKey |
UTXJJIRQAYXELZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. J Med Chem. 2008 Dec 11;51(23):7327-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.